460 related articles for article (PubMed ID: 15225321)
1. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
2. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
4. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y
Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
6. Methionine Antagonizes
Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
[No Abstract] [Full Text] [Related]
7. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
[TBL] [Abstract][Full Text] [Related]
8. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the promoter region of methionine transporter gene
Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W
mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948
[TBL] [Abstract][Full Text] [Related]
10. Detection of multidrug resistance in Mycobacterium tuberculosis.
Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
[TBL] [Abstract][Full Text] [Related]
12. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.
Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S
Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis.
Pandey B; Grover S; Kaur J; Grover A
Sci Rep; 2019 Sep; 9(1):13617. PubMed ID: 31541138
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains.
Wei W; Yan H; Zhao J; Li H; Li Z; Guo H; Wang X; Zhou Y; Zhang X; Zeng J; Chen T; Zhou L
Emerg Microbes Infect; 2019; 8(1):248-261. PubMed ID: 30866779
[TBL] [Abstract][Full Text] [Related]
15. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
16. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
[TBL] [Abstract][Full Text] [Related]
17. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Shenai S; Rodrigues C; Mehta A
Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
[TBL] [Abstract][Full Text] [Related]
18. Ethambutol resistance testing by mutation detection.
Johnson R; Jordaan AM; Pretorius L; Engelke E; van der Spuy G; Kewley C; Bosman M; van Helden PD; Warren R; Victor TC
Int J Tuberc Lung Dis; 2006 Jan; 10(1):68-73. PubMed ID: 16466040
[TBL] [Abstract][Full Text] [Related]
19. Competition between H
Yu JF; Xu JT; Feng A; Qi BL; Gu J; Deng JY; Zhang XE
Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38275323
[TBL] [Abstract][Full Text] [Related]
20. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
